Riskpilot← Back to searchSign inGet full accessINVIVO BIONICS AS
ASActiveOrg 920478840Gaustadalléen 21, 0349 OsloEngineering activities and related technical consultancy · NACE 7112Est. 20186 employees
Revenue 2024
NOK 7,1M
-72% vs 2023
EBITDA margin
-162.5%
-422% vs 2023
Equity ratio
23.9%
Financial strength
Net profit 2024
NOK -11,9M
-959% vs 2023
| Revenue | NOK 7,1M | -72% |
| EBITDA | NOK -11,5M | -422% |
| Net profit | NOK -11,9M | -959% |
| Total assets | NOK 22,7M | +73% |
| Equity | NOK 5,4M | +15% |
| Employees | 6 | — |
Legal name
INVIVO BIONICS AS
Org number
920478840
Legal form
Aksjeselskap
NACE code
7112 · Engineering activities and related technical consultancy
Founded
22. februar 2018
Share capital
NOK 53 118
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Utvikling, produksjon og konsulenttjenester for implanterbart medisinsk utstyr.
Address
Gaustadalléen 21, 0349 Oslo
Email
mail@norwayhealthtech.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 4 171 | 7 063 | 25 060 | 7 103 |
| Staff expenses | −102 | −1 731 | −3 916 | −7 014 | −9 526 |
| EBITDA | −169 | −1 087 | −1 637 | −2 210 | −11 544 |
| Depreciation & amort. | −5 | −41 | −118 | −125 | −98 |
| EBIT | −174 | −1 128 | −1 754 | −2 335 | −11 642 |
| Net financials | −5 | −9 | −24 | 1 212 | −257 |
| Profit before tax | −179 | −1 137 | −1 778 | −1 123 | −11 898 |
| Tax | −2 | −0 | −0 | −0 | −0 |
| Net profit | −177 | −1 137 | −1 778 | −1 123 | −11 898 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 964 | 8 854 | 20 440 | 13 066 | 22 663 |
| Equity | 113 | 7 138 | 5 346 | 4 734 | 5 424 |
| Long-term debt | 395 | 0 | 0 | 5 613 | 13 113 |
| Short-term debt | 456 | 1 716 | 15 094 | 2 719 | 4 125 |
| Total debt | 851 | 1 716 | 15 094 | 8 332 | 17 238 |
EBITDA margin
-162.5%
This company
15.8%
Market median
-1128% vs market
20202024
Equity ratio
23.9%
This company
38.2%
Market median
-37% vs market
20202024
Return on equity
-219.3%
This company
18.4%
Market median
-1292% vs market
20202024
Net profit margin
-167.5%
This company
8.1%
Market median
-2168% vs market
20202024
Asset turnover
0.31×
This company
1.12×
Market median
-72% vs market
20202024
Debt / equity
3.18×
This company
0.62×
Market median
-413% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
IC Chief Executive Officer | Chief Executive Officer | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Chairman | 2022 | |
| Board of Directors | 2025 | |
| Former (4) | ||
| Board of Directors | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 49.47% | 49.47% | 2024 | |
| Company | 9.25% | 9.25% | 2024 | |
| Company | 9.09% | 9.09% | 2024 | |
| Company | 7.04% | 7.04% | 2024 | |
| Company | 4.6% | 4.6% | 2024 | |
| Company | 4.44% | 4.44% | 2024 | |
| Company | 4.25% | 4.25% | 2024 | |
| Company | 2.08% | 2.08% | 2024 | |
| Company | 1.04% | 1.04% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ingelin Clausen Holding As
INVIVO BIONICS AS Board members of INVIVO BIONICS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ingelin Clausen | Chief Executive Officer | 0 companies |
| Gunnar Evensen | Board of Directors | 0 companies |
| Bo Arne Lennart Wagrell | Board of Directors | 0 companies |
| Stig Nordal | Chairman | 0 companies |
| Morten Åsli | Board of Directors | 0 companies |
| Anders Eikenes | Board of Directors | 0 companies |
| Joachim Dericq Paasche | Board of Directors | 0 companies |
| John Olof Solberg | Board of Directors | 0 companies |